Uso racional de medicamentos: temas selecionados, 2012.

Referências
1. LEWINGTON, S. et al. Age-specific relevance of
usual blood pressure to vascular mortality: a metaanalysis
of individual data for one million adults in 61
prospective studies. Lancet, London, n. 360, p. 1903-
1913, 2002. Prospective Studies Collaboration.
2. MOREIRA, L.B. et al. Incidence of hypertension
in Porto Alegre, Brazil: a population-based study.
Journal of Human Hypertension, London, n. 22, p.
48-50, 2008.
3. FUCHS, F.D. Blood pressure-lowering drugs:
essential therapy for some patients with normal
blood pressure. Expert Review of Cardiovascular
Therapy, London, n. 2, p. 771-775, 2004.
4. FUCHS, F.D. Diuretics: still essential drugs for
the management of hypertension. Expert Review
of Cardiovascular Therapy, London, n. 7, p. 591-
598, 2009.
5. FUCHS, F.D. Anti-hipertensivos. In: FUCHS, F.D.;
WANNMACHER, L. (Ed.) Farmacologia clínica:
fundamentos da terapêutica racional. Rio de Janeiro:
Guanabara Koogan, 2010. p. 843-861.
6. LAW, M.R.; MORRIS; J.K., WALD, N.J. Use of
blood pressure lowering drugs in the prevention
of cardiovascular disease: meta-analysis of 147
randomised trials in the context of expectations
from prospective epidemiological studies. BMJ,
London, n. 338, p. B1665, 2009
7. FUCHS, F.D. Prehypertension: the rationale for
early drug therapy. Cardiovascular Therapeutics,
[S.l.], v. 28, n. 6, p. 339-343, 2010.
8. FUCHS, F.D. The corporate bias and the molding
of prescription practices: the case of hypertension.
Brazilian Journal of Medical and Biological
Research, Ribeirão Preto, n. 42, p. 224-228, 2009.
9. THE ANTIHYPERTENSIVE and Lipid-Lowering
Treatment to Prevent Heart Attack Trial (ALLHAT).
Major outcomes in high-risk hypertensive patients
randomized to angiotensin-converting enzyme
inhibitor or calcium channel blocker vs. diuretic.
JAMA, Chicago, n. 288, p. 2981-2997, 2002. The
ALLHAT Collaborative Research Group.
10. RAHMAN, M. et al. Renal outcomes in
high-risk hypertensive patients treated with an
angiotensinconverting enzyme inhibitor or a calcium
channel blocker vs a diuretic: a report from the
Antihypertensive and Lipid-Lowering Treatment to
Prevent Heart Attack Trial (ALLHAT). Archives of
Internal Medicine, Chicago, n. 165, p. 936-946, 2005.
Uso Racional de Medicamentos: temas selecionados
113
11. BARZILAY, J.I. et al. Fasting glucose
levels and incident diabetes mellitus in older
nondiabetic adults randomized to receive 3
different classes of antihypertensive treatment:
a report from the Antihypertensive and Lipid-
Lowering Treatment to Prevent Heart Attack
Trial (ALLHAT). Archives of Internal Medicine,
Chicago, n. 166, p. 2191-2201, 2006.
12. FUCHS, F.D. Corporate influence over
planning and presentation of clinical trials: beauty
and the beast. Expert Review of Cardiovascular
Therapy, London, n. 8, p. 7-9, 2010.
13. LAW, M.R.; MORRIS, J.K.; WALD, N.J. Lowering
blood pressure to prevent myocardial infarction and
stroke: a new preventive strategy. Health Technology
Assessment, Rockville, n. 7, p. 1-94, 2003.
14. YUSUF, S. et al. Telmisartan, ramipril, or both
in patients at high risk for vascular events. New
England Journal of Medicine, Boston, n. 358, p.
1547-1559, 2008. Ontarget Investigators.
15. JAMERSON, K. et al. Benazepril plus
amlodipine or hydrochlorothiazide for hypertension
in high-risk patients. New England Journal of
Medicine, Boston, n. 359, p. 2417-2428, 2008.
16. FUCHS, F.D.; GUERRERO, P.; GUS, M. What
is next when the first blood pressure-lowering drug
is not sufficient? Expert Review of Cardiovascular
Therapy, London, n. 5, p. 435-439, 2007.
17. GUERRERO, P. et al. Blood pressure-lowering
efficacy of amiloride versus enalapril as add-on
drugs in patients with uncontrolled blood pressure
receiving hydrochlorothiazide. Clinical and
Experimental Hypertension, New York,
n. 30, p. 553-564, 2008.
18. HANSSON, L. et al. Effects of intensive
blood-pressure lowering and low-dose aspirin
in patients with hypertension: principal results
of the Hypertension Optimal Treatment (HOT)
randomised trial. HOT Study Group. Lancet,
London, n. 351, p. 1755-1762, 1998.
19. CUSHMAN, W.C. et al. Effects of intensive
blood-pressure control in type 2 diabetes mellitus.
New England Journal of Medicine, Boston, n. 362,
p. 1575-1585, 2010. The ACCORD Study Group.
20. ABALOS, E. et al. Antihypertensive drug
therapy for mild to moderate hypertension during
pregnancy. Cochrane Database of Systematic
Reviews, Oxford, Issue 1, 2007. CD002252.